Fred E. Cohen, Director at Intellia Therapeutics, Inc. (NTLA), bought 150,000 shares at $9.35 ($1.4M) on 2026-01-05, disclosed to the SEC on 2026-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| GHDX | SELL | 2018-11-13 | $1.3M | — | Filing → |
| GHDX | SELL | 2018-09-10 | $1.0M | — | Filing → |
| GHDX | SELL | 2018-08-09 | $464K | — | Filing → |